{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T11:10:47Z","timestamp":1778843447365,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"16","license":[{"start":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T00:00:00Z","timestamp":1720828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T00:00:00Z","timestamp":1720828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000053","name":"U.S. Department of Health & Human Services | NIH | National Eye Institute","doi-asserted-by":"publisher","award":["P30EY001765"],"award-info":[{"award-number":["P30EY001765"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Wilmer Rising Professorship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1038\/s41433-024-03227-6","type":"journal-article","created":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T22:01:32Z","timestamp":1720908092000},"page":"3093-3100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of systemic and demographic risk factors with prevalence of retinopathy in US adults with prediabetes"],"prefix":"10.1038","volume":"38","author":[{"given":"Kaela","family":"Bynoe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5171-6709","authenticated-orcid":false,"given":"Mira M.","family":"Sachdeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,13]]},"reference":[{"key":"3227_CR1","doi-asserted-by":"publisher","first-page":"405","DOI":"10.4172\/2155-9570.1000405","volume":"6","author":"KH Nwanyanwu","year":"2015","unstructured":"Nwanyanwu KH, Newman-Casey PA, Gardner TW, Lim JI. Beyond HbA1c: environmental risk factors for diabetic retinopathy. J Clin Exp Ophthalmol. 2015;6:405.","journal-title":"J Clin Exp Ophthalmol"},{"key":"3227_CR2","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.2337\/dc23-S002","volume":"46","author":"NA ElSayed","year":"2023","unstructured":"ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 2. Classification and diagnosis of diabetes: standards of care in diabetes-2023. Diabetes Care. 2023;46:S19\u2013S40.","journal-title":"Diabetes Care"},{"key":"3227_CR3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1464-5491.2007.02043.x","volume":"24","author":"Diabetes Prevention Program Research Group.","year":"2007","unstructured":"Diabetes Prevention Program Research Group. The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program. Diabet Med. 2007;24:137\u201344.","journal-title":"Diabet Med"},{"key":"3227_CR4","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","volume":"157","author":"P Saeedi","year":"2019","unstructured":"Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pr. 2019;157:107843.","journal-title":"Diabetes Res Clin Pr"},{"key":"3227_CR5","doi-asserted-by":"publisher","first-page":"e040997","DOI":"10.1136\/bmjopen-2020-040997","volume":"11","author":"V Kirthi","year":"2021","unstructured":"Kirthi V, Nderitu P, Alam U, Evans J, Nevitt S, Malik RA, et al. Prevalence of retinopathy in prediabetes: protocol for a systematic review and meta-analysis. BMJ Open. 2021;11:e040997.","journal-title":"BMJ Open"},{"key":"3227_CR6","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","volume":"379","author":"AG Tab\u00e1k","year":"2012","unstructured":"Tab\u00e1k AG, Herder C, Rathmann W, Brunner EJ, Kivim\u00e4ki M. Prediabetes: a high-risk state for diabetes development. Lancet 2012;379:2279\u201390.","journal-title":"Lancet"},{"key":"3227_CR7","doi-asserted-by":"publisher","first-page":"e000907","DOI":"10.1136\/bmjdrc-2019-000907","volume":"8","author":"GS Fazli","year":"2020","unstructured":"Fazli GS, Moineddin R, Bierman AS, Booth GL. Ethnic variation in the conversion of prediabetes to diabetes among immigrant populations relative to Canadian-born residents: a population-based cohort study. BMJ Open Diabetes Res Care. 2020;8:e000907.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"3227_CR8","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1161\/CIRCULATIONAHA.116.023446","volume":"134","author":"BM S\u00f6rensen","year":"2016","unstructured":"S\u00f6rensen BM, Houben AJ, Berendschot TT, Schouten JS, Kroon AA, van der Kallen CJ, et al. Prediabetes and type 2 diabetes are associated with generalized microvascular dysfunction: the Maastricht Study. Circulation 2016;134:1339\u201352.","journal-title":"Circulation"},{"key":"3227_CR9","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1167\/iovs.16-19638","volume":"58","author":"EEB De Clerck","year":"2017","unstructured":"De Clerck EEB, Schouten JSAG, Berendschot TTJM, Beckers HJM, Schaper NC, Shram MT, et al. Loss of temporal peripapillary retinal nerve fibers in prediabetes or type 2 diabetes without diabetic retinopathy: the Maastricht Study. Invest Ophthalmol Vis Sci. 2017;58:1017\u201327.","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"3227_CR10","doi-asserted-by":"publisher","first-page":"968","DOI":"10.2337\/diab.44.8.968","volume":"44","author":"The Diabetes Control and Complications Trial Research Group.","year":"1995","unstructured":"The Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes. 1995;44:968\u201383.","journal-title":"Diabetes"},{"key":"3227_CR11","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1046\/j.1365-2125.1999.00092.x","volume":"48","author":"P King","year":"1999","unstructured":"King P, Peacock I, Donnelly R. The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes. Br J Clin Pharm. 1999;48:643\u20138.","journal-title":"Br J Clin Pharm"},{"key":"3227_CR12","doi-asserted-by":"publisher","first-page":"875","DOI":"10.2337\/dc18-2308","volume":"42","author":"DP Hainsworth","year":"2019","unstructured":"Hainsworth DP, Bebu I, Aiello LP, Sivitz W, Gubitosi-Klug R, Malone J, et al. Risk factors for retinopathy in type 1 diabetes: the DCCT\/EDIC Study. Diabetes Care. 2019;42:875\u201382.","journal-title":"Diabetes Care"},{"key":"3227_CR13","first-page":"72","volume":"107","author":"C Farrell","year":"2014","unstructured":"Farrell C, Moran J. Comparison of comorbidities in patients with pre-diabetes to those with diabetes mellitus type 2. Ir Med J. 2014;107:72\u20134.","journal-title":"Ir Med J"},{"key":"3227_CR14","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.2337\/dc22-0860","volume":"45","author":"NH White","year":"2022","unstructured":"White NH, Pan Q, Knowler WC, Schroeder EB, Dabelea D, Chew EY, et al. Risk factors for the development of retinopathy in prediabetes and type 2 diabetes: the Diabetes Prevention Program Experience. Diabetes Care. 2022;45:2653\u201361.","journal-title":"Diabetes Care"},{"key":"3227_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/02713683.2019.1659977","volume":"45","author":"YK Bao","year":"2020","unstructured":"Bao YK, Yan Y, Wilson B, Gordon MO, Semenkovich CF, Rajagopal R. Association of retinopathy and insulin resistance: NHANES 2005-8. Curr Eye Res. 2020;45:173\u20136.","journal-title":"Curr Eye Res"},{"key":"3227_CR16","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.1167\/iovs.19-28063","volume":"60","author":"YK Bao","year":"2019","unstructured":"Bao YK, Yan Y, Gordon M, McGill JB, Kass M, Rajagopal R. Visual field loss in patients with diabetes in the absence of clinically-detectable vascular retinopathy in a Nationally Representative Survey. Invest Ophthalmol Vis Sci. 2019;60:4711\u20136.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3227_CR17","doi-asserted-by":"crossref","unstructured":"Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991;98(Suppl 5):786\u2013806.","DOI":"10.1016\/S0161-6420(13)38012-9"},{"key":"3227_CR18","first-page":"98","volume":"104","author":"R Klein","year":"2006","unstructured":"Klein R, Klein BE, Moss SE, Wong TY. The relationship of retinopathy in persons without diabetes to the 15-year incidence of diabetes and hypertension: Beaver Dam Eye Study. Trans Am Ophthalmol Soc. 2006;104:98\u2013107.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"3227_CR19","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.1167\/iovs.07-0206","volume":"48","author":"JR Chao","year":"2007","unstructured":"Chao JR, Lai M-Y, Azen SP, Klein R, Varma R, Los Angeles Latino Eye Study Group. Retinopathy in persons without diabetes: the Los Angeles Latino Eye Study. Invest Ophthalmol Vis Sci. 2007;48:4019\u201325.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3227_CR20","doi-asserted-by":"publisher","first-page":"e001776","DOI":"10.1136\/bmjdrc-2020-001776","volume":"9","author":"UP Gujral","year":"2021","unstructured":"Gujral UP, Jagannathan R, He S, Huang M, Staimez LR, Wei J, et al. Association between varying cut-points of intermediate hyperglycemia and risk of mortality, cardiovascular events and chronic kidney disease: a systematic review and meta-analysis. BMJ Open Diabetes Res Care. 2021;9:e001776.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"3227_CR21","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1136\/bmj.308.6940.1323","volume":"308","author":"DR McCance","year":"1994","unstructured":"McCance DR, Hanson RL, Charles MA, Jacobsson LT, Pettitt DJ, Bennett PH, et al. Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ. 1994;308:1323\u20138.","journal-title":"BMJ."},{"key":"3227_CR22","doi-asserted-by":"publisher","first-page":"785","DOI":"10.2337\/diacare.20.5.785","volume":"20","author":"MM Engelgau","year":"1997","unstructured":"Engelgau MM, Thompson TJ, Herman WH, Boyle JP, Aubert RE, Kenny SJ, et al. Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited. Diabetes Care. 1997;20:785\u201391.","journal-title":"Diabetes Care"},{"key":"3227_CR23","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.2337\/diacare.26.2007.S5","volume":"26","author":"Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.","year":"2003","unstructured":"Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26:S5\u201320.","journal-title":"Diabetes Care"},{"key":"3227_CR24","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S2213-8587(18)30027-5","volume":"6","author":"MK Ali","year":"2018","unstructured":"Ali MK, Bullard KM, Saydah S, Imperatore G, Gregg EW. Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988-2014. Lancet Diabetes Endocrinol. 2018;6:392\u2013403.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3227_CR25","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.amjcard.2015.08.015","volume":"116","author":"JE Grunwald","year":"2015","unstructured":"Grunwald JE, Pistilli M, Ying GS, Maguire M, Daniel E, Whittock-Martin R, et al. Retinopathy and the risk of cardiovascular disease in patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort study). Am J Cardiol. 2015;116:1527\u201333.","journal-title":"Am J Cardiol"},{"key":"3227_CR26","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1097\/IAE.0000000000003337","volume":"42","author":"V Kirthi","year":"2022","unstructured":"Kirthi V, Zuckerman BP, Alam U, Bunce C, Hopkins D, Jackson TL. Associations between dysglycemia, retinal neurodegeneration, and microalbuminuria in prediabetes and type 2 diabetes. Retina. 2022;42:442\u20139.","journal-title":"Retina."},{"key":"3227_CR27","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s001250051594","volume":"44","author":"IM Stratton","year":"2001","unstructured":"Stratton IM, Kohner EM, Aldington SJ, Turner RC, Holman RR, Manley SE, et al. UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia. 2001;44:156\u201363.","journal-title":"Diabetologia."},{"key":"3227_CR28","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.ophtha.2006.10.023","volume":"114","author":"R Varma","year":"2007","unstructured":"Varma R, Macias GL, Torres M, Klein R, Pena FY, Azen SP, et al. Biologic risk factors associated with diabetic retinopathy: the Los Angeles Latino Eye Study. Ophthalmology. 2007;114:1332\u201340.","journal-title":"Ophthalmology."},{"key":"3227_CR29","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1016\/j.ophtha.2008.08.023","volume":"115","author":"R Klein","year":"2008","unstructured":"Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology. 2008;115:1859\u201368.","journal-title":"Ophthalmology."},{"key":"3227_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-13593-4","volume":"12","author":"J Qian","year":"2022","unstructured":"Qian J, Haq Z, Yang D, Stewart JM. Male sex increases the risk of diabetic retinopathy in an urban safety-net hospital population without impacting the relationship between axial length and retinopathy. Sci Rep. 2022;12:9780.","journal-title":"Sci Rep"},{"key":"3227_CR31","doi-asserted-by":"publisher","first-page":"5814296","DOI":"10.1155\/2020\/5814296","volume":"2020","author":"M Li","year":"2020","unstructured":"Li M, Wang Y, Liu Z, Tang X, Mu P, Tan Y, et al. Females with type 2 diabetes mellitus are prone to diabetic retinopathy: a twelve-province cross-sectional study in China. J Diabetes Res. 2020;2020:5814296.","journal-title":"J Diabetes Res"},{"key":"3227_CR32","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/j.diabres.2013.12.043","volume":"103","author":"A Kajiwara","year":"2014","unstructured":"Kajiwara A, Miyagawa H, Saruwatari J, Kita A, Sakata M, Kawata Y, et al. Gender differences in the incidence and progression of diabetic retinopathy among Japanese patients with type 2 diabetes mellitus: a clinic-based retrospective longitudinal study. Diabetes Res Clin Pr. 2014;103:e7\u201310.","journal-title":"Diabetes Res Clin Pr"},{"key":"3227_CR33","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12933-021-01290-x","volume":"20","author":"R de Ritter","year":"2021","unstructured":"de Ritter R, Sep SJS, van der Kallen CJH, van Greevenbroek MMJ, de Jong M, Vos RC, et al. Sex differences in the association of prediabetes and type 2 diabetes with microvascular complications and function: the Maastricht Study. Cardiovasc Diabetol. 2021;20:102.","journal-title":"Cardiovasc Diabetol"},{"key":"3227_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-40987-8","volume":"9","author":"S Kanmani","year":"2019","unstructured":"Kanmani S, Kwon M, Shin MK, Kim MK. Association of C-reactive protein with risk of developing type 2 diabetes mellitus, and role of obesity and hypertension: a large population-based Korean cohort study. Sci Rep. 2019;9:4573.","journal-title":"Sci Rep"},{"key":"3227_CR35","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jcjd.2018.03.007","volume":"43","author":"K Kato","year":"2019","unstructured":"Kato K, Otsuka T, Saiki Y, Kobayashi N, Nakamura T, Kon Y, et al. Association between elevated C-reactive protein levels and prediabetes in adults, particularly impaired glucose tolerance. Can J Diabetes. 2019;43:40\u201345.e2.","journal-title":"Can J Diabetes"},{"key":"3227_CR36","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.4103\/IJO.IJO_345_23","volume":"71","author":"CU Bhutia","year":"2023","unstructured":"Bhutia CU, Kaur P, Singh K, Kaur S. Evaluating peripheral blood inflammatory and metabolic biomarkers as predictors in diabetic retinopathy and diabetic macular edema. Indian J Ophthalmol. 2023;71:2521\u20135.","journal-title":"Indian J Ophthalmol"},{"key":"3227_CR37","doi-asserted-by":"publisher","first-page":"e0144406","DOI":"10.1371\/journal.pone.0144406","volume":"10","author":"J Song","year":"2015","unstructured":"Song J, Chen S, Liu X, Duan H, Kong J, Li Z. Relationship between C-reactive protein level and diabetic retinopathy: a systematic review and meta-analysis. PLoS ONE. 2015;10:e0144406.","journal-title":"PLoS ONE"},{"key":"3227_CR38","doi-asserted-by":"publisher","first-page":"4458","DOI":"10.1167\/iovs.09-4939","volume":"51","author":"LS Lim","year":"2010","unstructured":"Lim LS, Tai ES, Mitchell P, Wang JJ, Tay WT, Lamoureux E, et al. C-reactive protein, body mass index, and diabetic retinopathy. Invest Ophthalmol Vis Sci. 2010;51:4458\u201363.","journal-title":"Invest Ophthalmol Vis Sci."}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03227-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03227-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03227-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T16:02:46Z","timestamp":1730995366000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03227-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,13]]},"references-count":38,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["3227"],"URL":"https:\/\/doi.org\/10.1038\/s41433-024-03227-6","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,13]]},"assertion":[{"value":"16 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}